Dongdong Wang

Dongdong Wang is a dedicated researcher in the field of AI for Science, currently serving as Co-President of Drug Discovery at DP Technology and Head of Computational Biology at Atombeat Inc. Their work focuses on advancing drug discovery through the development of the RiDYMO platform, which utilizes artificial intelligence and molecular simulation to target challenging proteins. Dongdong earned a Ph.D. in Computational Biology from Fudan University and a B.S. in Bioinformatics from Soochow University, furthering their commitment to leveraging cutting-edge technologies to address unmet medical needs. Previously, they held a postdoctoral researcher position at Princeton University.